Bayer Pharma Head Tapped to Replace Oxford GlycoSciences CEO

genomeweb
360dx

Bayer Pharma Head Tapped to Replace Oxford GlycoSciences CEO

May 24, 2002

NEW YORK, May 24 - Oxford GlycoSciences today said it has hired David Ebsworth to take over the CEO post after Michael Kranda leaves on July 11.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Real-Time Lassa Virus Genome Analysis Shows Increase in Cases Not Due to New Strain
BioMérieux Q3 Revenues Grow 7 Percent
BGI Americas, Gencove Partner on Sequencing Service
Illumina Accelerator Program Adds Five Startups to Eighth Investment Cycle
Common Tuberculosis Lineage Spread With European Colonization, Analysis Indicates
Acute Myeloid Leukemia Analysis Brings Together Integrated 'Omic, Drug Response Profiles

The Scan

Microsoft, But the Brain, Too

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

Been Reclassified

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

This Week in Cell

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Pursuit of a Cancer Vaccine

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Main menu